| Bioactivity | CGP 57813 is a peptidomimetic inhibitor of HIV protease that can be encapsulated by nanoparticles composed of poly(D,L-lactic acid) (PLA) and pH-sensitive methacrylic acid copolymers and delivered into the body[1]. |
| CAS | 150608-41-6 |
| Formula | C43H58N4O8 |
| Molar Mass | 758.94 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Leroux JC, et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci. 1995 Dec;84(12):1387-91. |
CGP 57813
CAS: 150608-41-6 F: C43H58N4O8 W: 758.94
CGP 57813 is a peptidomimetic inhibitor of HIV protease that can be encapsulated by nanoparticles composed of poly(D,L-l
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.